Related Experiment Video

Updated: Jun 11, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Hereditary muscular dystrophies and the heart

M C E Hermans1, Y M Pinto, I S J Merkies

  • 1Department of Neurology, Maastricht University Medical Centre, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands. m.hermans@mumc.nl

Neuromuscular Disorders : NMD
|July 15, 2010
PubMed

Insights

Cardiac disease is common in muscular dystrophies, affecting heart muscle and conduction. Early detection and management are crucial for patient prognosis, despite diagnostic challenges.

Area of Science:

  • Cardiology
  • Neurology
  • Genetics

Background:

  • Cardiac disease frequently manifests in patients with neuromuscular disorders, especially muscular dystrophies.
  • Both the heart muscle (myocardium) and specialized conducting fibers can be impacted by the dystrophic process.
  • Cardiac involvement varies significantly across different types of muscular dystrophies.

Purpose of the Study:

  • To provide a comprehensive overview of hereditary muscular dystrophies associated with cardiac disease.
  • To outline an efficient strategy for the diagnosis and management of cardiac complications in these disorders.
  • To highlight the importance of recognizing cardiac involvement for patient prognosis.

Main Methods:

  • This review synthesizes current literature on cardiac manifestations in hereditary muscular dystrophies.
  • It examines the varying incidence and nature of cardiac involvement based on dystrophy type.
  • The review discusses diagnostic challenges and the need for active investigation.

Main Results:

  • Muscular dystrophies can lead to myocardial disease (cardiomyopathy, heart failure) or conduction system abnormalities (arrhythmias, sudden death).
  • Prognosis in muscular dystrophy patients is often directly linked to their cardiac status.
  • Cardiac dysfunction may be asymptomatic or present unpredictably, complicating early recognition.

Conclusions:

  • Cardiac surveillance and timely management are essential for improving outcomes in muscular dystrophy patients.
  • Understanding the specific cardiac risks associated with different muscular dystrophies is critical for effective care.
  • Developing efficient diagnostic and management strategies is key to addressing these complex conditions.

More Related Videos

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice08:13

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

Isometric and Eccentric Force Generation Assessment of Skeletal Muscles Isolated from Murine Models of Muscular Dystrophies14:10

Isometric and Eccentric Force Generation Assessment of Skeletal Muscles Isolated from Murine Models of Muscular Dystrophies

Published on: January 31, 2013

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...